Making genetic diversity easier to access and understand
Official title: Building Tools and Community to Make Pangenomes Accessible
Funded at University of Tennessee Health Sci Ctr · NIH-10978097 · Data updated 2026-11-12
This study is working on new tools to help people understand the full range of human genetic diversity, which can give patients better insights into their own genes and how they might affect their health.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Tennessee Health Sci Ctr NIH-funded |
| Lab location | 1 site (Memphis, United States) |
| Project start | September 19, 2024 |
| Project end | August 31, 2027 |
| Funding year | 2024 |
| Award (this year) | $1,645,076 |
| NIH project number | 1U01HG013760-01 |
| Project ID | NIH-10978097 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates include individuals interested in genetic research or those with conditions influenced by genetic variation.
✕Less likely to help
Patients with no interest in genetic research or those whose conditions are not influenced by genetic factors may not benefit from this research.
What this research studies
This research focuses on developing innovative tools to access and interpret the human pangenome, which includes the vast genetic diversity not captured by any single reference genome. By creating advanced sequence alignment and visualization methods, the project aims to facilitate the exploration of genetic variations across populations. Patients may benefit from improved understanding of their genetic makeup and how it relates to health and disease. The research will also involve engaging with genomics communities through workshops and open-source software.
Why it matters
Potential benefit: If successful, this research could enhance personalized medicine by providing deeper insights into genetic diversity and its implications for health.
How similar studies have gone: Similar research efforts have shown promise in enhancing genomic understanding and accessibility, indicating a potential for success in this novel approach.
Where this research is happening
-
University of Tennessee Health Sci Ctr
Memphis, United States Active
Researchers
- Principal investigator: Garrison, Erik — University of Tennessee Health Sci Ctr
- Study coordinator: Garrison, Erik
Related research
Other NIH-funded projects on the same topics.
-
EP2 blockers to protect the brain after a stroke
Aims to test brain-permeable EP2 antagonists to reduce damage after ischemic stroke and improve recovery.
-
HIV drugs may also stop a dangerous fungus from growing
A cancer/antifungal researcher is exploring whether HIV medicines can help treat cryptococcal infections in people with HIV/AIDS.
-
Profiling immune cells to find early inflammation clues in kids with obesity and insulin resistance
This project looks at how immune cells in children with obesity may show early inflammatory changes linked to insulin resistance.
-
Targeted inhibitors to block a key enzyme and fight metastatic triple-negative breast cancer
A new drug candidate aimed at a specific enzyme in cancer cells is being developed to stop the spread of metastatic triple-negative breast cancer.
-
New fungal partner targets to curb Aspergillus infection in vulnerable patients
A NIH-funded project is exploring how the fungus Aspergillus fumigatus grows and causes serious infections in people with weakened immune systems, with the aim of finding new ways to stop it.
-
Epigenetic control of aging heart function
A scientist at a university is studying how aging changes heart function and whether a specific gene, KDM6A, influences this process to uncover ways to prevent or treat aging-related heart problems.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.